Urinary Trypsin Inhibitor Fragment

Urinary Trypsin Inhibitor Fragment is a fragment derived from urinary trypsin inhibitor by proteolysis. Urinary Trypsin Inhibitor Fragment can inhibit tumor cell invasion by limited proteolysis[1].

Product Specifications

CAS Number

[164859-77-2]

UNSPSC

12352209

Target

Ser/Thr Protease

Type

Biochemical Assay Reagents

Related Pathways

Metabolic Enzyme/Protease

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/urinary-trypsin-inhibitor-fragment.html

Solubility

10 mM in DMSO

Smiles

CC[C@H](C)[C@@H](C(O)=O)NC([C@H](CC1=CC=CC=C1)NC([C@H](C)NC([C@H](CCCNC(N)=N)NC([C@H](CS)NC([C@H]2N(CCC2)C(CNC([C@@H](N)CCCNC(N)=N)=O)=O)=O)=O)=O)=O)=O

Molecular Formula

C40H66N14O9S

Molecular Weight

919.11

References & Citations

[1]Kobayashi H, et, al. Urinary trypsin inhibitor (UTI) and fragments derived from UTI by limited proteolysis efficiently inhibit tumor cell invasion. Clin Exp Metastasis. 1994 Mar;12 (2) :117-28.